During the past decade, Kolding Sygehus conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 7 clinical trials were completed, i.e. on average, 21.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 3 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kolding Sygehus" #1 sponsor was "Kolding Sygehus" with 6 trials, followed by "University of Southern Denmark" with 6 trials sponsored, "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Sygehus Lillebaelt" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kolding Sygehus" #1 collaborator was "Kolding Sygehus" with 5 trials as a collaborator, "Odense University Hospital" with 5 trials as a collaborator, "Aarhus University Hospital" with 4 trials as a collaborator, "Hvidovre University Hospital" with 4 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Kolding Sygehus" are "COVID" (4 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Acute Disease" (1 trials). Many other conditions were trialed in "Kolding Sygehus" in a lesser frequency.

Most popular intervention types in "Kolding Sygehus" are "Drug" (19 trials), "Other" (15 trials), "Procedure" (8 trials), "Biological" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)" (2 trials), "LeucoPatch" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kolding Sygehus" are 46 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kolding Sygehus". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Kolding Sygehus, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kolding Sygehus, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 15 trials that are defined as “Not Applicable".